BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2024 5:28:10 AM | Browse: 136 | Download: 647
 |
Received |
|
2023-10-12 03:52 |
|
Peer-Review Started |
|
2023-09-29 21:50 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-18 01:08 |
|
Revised |
|
2023-12-18 05:36 |
|
Second Decision |
|
2023-12-26 03:24 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-12-26 08:35 |
|
Articles in Press |
|
2023-12-26 08:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-05 02:18 |
|
Publish the Manuscript Online |
|
2024-01-11 05:28 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Chemotherapy combined with bevacizumab for small cell lung cancer with brain metastases: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hong-Yu Yang, Yu-Qing Xia, Yu-Jia Hou, Peng Xue, Shi-Jie Zhu and Dian-Rong Lu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81973640 |
| Nursery Program of Wangjing Hospital, Chinese Academy of Traditional Chinese Medicine |
WJYY-YJKT-2022-05 |
| Yu-Qing Xia Famous Old Chinese Medicine Heritage Workshop of “3+3” Project of Traditional Chinese Medicine Heritage in Beijing, Jing Zhong Yi Ke Zi (2021) |
73 |
| China Academy of Traditional Chinese Medicine Wangjing Hospital High-Level Chinese Medicine Hospital Construction Project Chinese Medicine Clinical Evidence-Based Research: The Evidence-Based Research of Electrothermal Acupuncture for Relieving Cancer-Related Fatigue in Patients With Malignant Tumor |
WYYY-XZKT-2023-20 |
|
| Corresponding Author |
Dian-Rong Lu, Doctor, PhD, Chief Physician, Professor, Department of Oncology, Wangjing Hospital, China Academy of Chinese Medical Sciences, No. 6 Huajiadi Street, Chaoyang District, Beijing 100102, China. ludianrong@aliyun.com |
| Key Words |
Small cell lung cancer; Bevacizumab; Brain metastasis; Antineoplastic agents; Target therapies; Immunotherapy; Radiotherapy; Case report |
| Core Tip |
Small cell lung cancer (SCLC) accounts for approximately 13%-15% of all lung cancer patients. A five-year survival rate of less than 7 percent makes it one of the deadliest cancers. Compared to Non-Small Cell Lung Carcinoma, SCLC has a faster doubling time in the early stages and is more likely to spread widely. Therefore, 60%-70% of SCLC is diagnosed as extensive stage at initial diagnosis. SCLC cells also show a high tendency of metastasis to the central nervous system, and 10% of patients have brain metastasis at the first visit. Here, we report a patient with extensive stage-small cell lung cancer (ES-SCLC) and brain metastases who received four lines of treatment. We used bevacizumab in combination with irinotecan as a post-fourth-line therapy in an elderly man and achieved a significant partial response. |
| Publish Date |
2024-01-11 05:28 |
| Citation |
Yang HY, Xia YQ, Hou YJ, Xue P, Zhu SJ, Lu DR. Chemotherapy combined with bevacizumab for small cell lung cancer with brain metastases: A case report. World J Clin Cases 2023; 12(2): 405-411 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i2/405.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i2.405 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
